SNT
Click for more information
3.03% 3.2¢ syntara limited

Is this imminent FDA feedback on the interim results from the...

  1. diersel
    443 Posts.
    lightbulb Created with Sketch. 7
    clock Created with Sketch.
    24/07/23
    13:47
    Post #: 68946869
    Is this imminent FDA feedback on the interim results from the mono therapy study or on the design protocol for the upcoming combined study with JAK inhibitor?
    PXS Price at posting: 5.2¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

RDN Raiden Resources hopeful it can start drilling Andover South, WA, as early as mid-October
right-arrow Created with Sketch.
NEWS How institutional adoption is shaping the future of crypto
right-arrow Created with Sketch.
SBW Shekel Brainweigh provides key business update ahead of final 2024 quarter
right-arrow Created with Sketch.
watchlist Created with Sketch. Add SNT (ASX) to my watchlist
(20min delay)
Last
3.2¢ 		Change
-0.001(3.03%) 		Mkt cap ! $41.29M
Open High Low Value Volume
3.3¢ 3.3¢ 3.2¢ $92.34K 2.853M

Buyers (Bids)

No. Vol. Price($)
1 384 3.2¢
 

Sellers (Offers)

Price($) Vol. No.
3.3¢ 443289 1
View Market Depth
Last trade - 16.10pm 23/08/2024 (20 minute delay) ?
SNT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.